Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NUCLEIC ACID DELIVERY FORMULATIONS
Document Type and Number:
WIPO Patent Application WO2002057424
Kind Code:
A3
Abstract:
The invention is based on the discovery that injectable and nucleic acid-compatible polymeric compositions and formulations can be structurally designed to regulate nucleic acid activity or gene expression in vivo , for example, by controlling the bioavailability of the nucleic acid via modulation of the biodegradability and crosslink density of the network formed by the components of the formulation. The polymeric network encases the nucleic acid, not only controlling the release of the DNA, but also providing protection from degradation. The invention described herein improves upon prior modes of gene delivery, in that gene expression can be regulated by modulation of a polymeric network formed by combination of at least two water-soluble components capable of reacting with one another. The nucleic acid of interest is incorporated into the network to be released in a sustained manner to achieve level and duration of activity or expression needed.

More Like This:
JP2007001923N-ACETYLGLUCOSAMINE SUGAR CHAIN-RECOGNIZING PROTEIN
JP2002531100INDUSTRIAL APPLICABILITY A method and system for detecting oligonucleotides in a sample.
JP2004035562VACCINE FOR TREATING LYMPHOMA AND LEUKEMIA
Inventors:
BARMAN SHIKHA P (US)
ROY KRISHNENDU (US)
HEDLEY MARY LYNNE (US)
WANG DAQING (US)
Application Number:
PCT/US2002/001379
Publication Date:
October 03, 2002
Filing Date:
January 17, 2002
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ZYCOS INC (US)
BARMAN SHIKHA P (US)
ROY KRISHNENDU (US)
HEDLEY MARY LYNNE (US)
WANG DAQING (US)
International Classes:
C12N15/09; A61K9/19; A61K35/76; A61K47/10; A61K47/24; A61K47/26; A61K47/32; A61K47/34; A61K47/36; A61K47/40; A61K48/00; C12N5/10; A61K9/00; (IPC1-7): C12N15/63; A61K9/127; A61K48/00; C12N15/88
Foreign References:
US6043094A2000-03-28
US6132765A2000-10-17
US5534259A1996-07-09
US6127499A2000-10-03
US5412023A1995-05-02
US5972707A1999-10-26
Other References:
See also references of EP 1352072A4
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: ISOLATING CELLS EXPRESSING SECRETED PROTEINS

Next Patent: NUCLEOSIDE DERIVATIVES AS INHIBITORS OF RNA-DEPENDENT RNA VIRAL POLYMERASE